This is a paid press release. Contact the press release distributor directly with any inquiries.
Dr. Wallace Brucker Launches Medically Supervised GLP-1 Weight Loss Program in Las Vegas Built to Prevent Muscle Loss
LV Longevity Lab
Fri, July 24, 2026 at 11:55 PM GMT+5:30
4 min read
As new data shows up to 40% of GLP-1 weight loss may be lean muscle, LV Longevity Lab pairs semaglutide and tirzepatide therapy with muscle-preservation protocols for safer, longer-lasting results
LAS VEGAS, NV /ACCESS Newswire/ July 24, 2026 /Amid growing concern that popular weight-loss medications may cost patients as much muscle as fat, Dr. Wallace Brucker, a board-certified surgeon and longevity medicine expert, has announced a medically supervised GLP-1 weight loss program at LV Longevity Lab in Las Vegas designed specifically to preserve lean muscle while patients lose fat
GLP-1 receptor agonists such as semaglutide and tirzepatide have transformed weight management, but long-term data emerging in 2025 and 2026 has surfaced a serious concern. Research indicates that a substantial portion of the weight lost on high-dose GLP-1 therapy is not fat but lean body mass, including skeletal muscle. Because muscle does not return as easily as fat, this loss can compromise strength, mobility, metabolism, and long-term health, particularly in adults over 50
The Problem With Weight Loss That Ignores Muscle
The concern has prompted a shift in how leading physicians prescribe these medications. Rather than focusing solely on the number on the scale, longevity-focused clinicians now emphasize body composition – the ratio of fat to muscle – as the true measure of a healthy outcome
“The scale is one of the most misleading tools in medicine,” said Dr. Brucker. “A patient can lose thirty pounds and celebrate, while quietly losing the muscle that protects their metabolism, their mobility, and their independence for decades to come. Muscle is not cosmetic – it is the armor that carries you through a long, resilient life. My job is to make sure that when a patient loses weight on a GLP-1, they lose fat and keep muscle. Done correctly, these medications are extraordinary. Done carelessly, they can accelerate the very decline we’re trying to prevent.”
A Program Built Around Body Composition
Dr. Brucker’s program combines medically supervised GLP-1 therapy with a structured muscle-preservation strategy grounded in the protocols now recommended by leading longevity physicians
Every patient begins with comprehensive baseline testing, including detailed body composition analysis that measures lean mass and fat mass separately rather than relying on weight alone. This establishes a starting point and allows muscle to be tracked throughout treatment, so any early lean-mass loss is caught and corrected before it compromises results
